Evaluation of Bionike one-step tests for the detection of drugs of abuse in urine

Annals of Clinical Biochemistry

Volumn 34, Issue 1, 1997, Pages 74-80

  Brown, E R S ^a   Jarvie, D R ^a   Simpson, D ^a  

^a ROYAL INFIRMARY OF EDINBURGH   (United Kingdom)

Author keywords

Amphetamines; Cannabinoids; Methacdone; Opiates

Indexed keywords

AMPHETAMINE DERIVATIVE; BENZODIAZEPINE DERIVATIVE; CANNABINOID; METHADONE; METHAMPHETAMINE; OPIATE;

ARTICLE; CONTROLLED STUDY; DRUG ABUSE; DRUG DETERMINATION; DRUG URINE LEVEL; ENZYME IMMUNOASSAY; GAS CHROMATOGRAPHY; HUMAN; LABORATORY TEST; MAJOR CLINICAL STUDY; MASS SPECTROMETRY; PRIORITY JOURNAL; URINALYSIS;

EID: 0031015157     PISSN: 00045632     EISSN: None     Source Type: Journal    
DOI: 10.1177/000456329703400111     Document Type: Article

References (22)

1. Armbruster DA, Krolak JM. Screening for drugs of abuse with the Roche ONTRAK assays. J Anal Toxicol 1992; 16: 172-5
2. Towt J, Tsai S-CJ, Hernandez MR, Klimov AD, Kravec CV, Rouse SL, et al. ONTRAK TESTCUP: A novel, on-site, multi-analyte screen for the detection of abused drugs. J Anal Toxicol 1995; 19: 504-10
3. Buechler KF, Moi S, Noar B, McGrath D, Villela J, Clancy M, et al. Simultaneous detection of seven drugs of abuse by the Triage panel for drugs of abuse. Clin Chem 1992; 38: 1678-84
4. Kaferstein H, Sticht G. Diagnostic observations with the methadone and cannabis 50 assay on the new Triage™ 7 Panel for drugs of abuse. GIT Lab Med 1994; 17: 266-70
5. Borland W, McKenzie L, Stewart M. An assessment of the Triage drugs of abuse screening cassette. In: Halloran SP, Martin SM, eds. Proceedings of the ACB National Meeting, Glasgow, 1995, May 8-12. London: RSM Press, 1995: 166
6. Wu AHB, Wong SS, Johnson KG, Callies J, Shu DX, Dunn WE, et al. Evaluation of the Triage system for emergency drugs-of-abuse testing in urine. J Anal Toxicol 1993; 17: 241-5
7. George S, Braithwaite RA. A preliminary evaluation of five rapid detection kits for on site drugs of abuse screening. Addiction 1995; 90: 227-32
8. Moore FML, Jarvie DR, Simpson D. Urinary amphetamines, benzodiazepines and methadone: cost effective detection procedures. Med Lab Sci 1992; 49: 27-33
9. Moore FML, Simpson D. Detection of cannabinoids in urine: a cost-effective low risk immunoassay procedure. Med Lab Sci 1991; 48: 76-9
10. Moore FML, Simpson D. Detection of opiates in urine: a cost-effective low risk immunoassay procedure. Med Lab Sci 1989; 46: 309-12
11. Crane T, Dawson CM, Tickner TR. False-positive results from Syva EMIT d.a.u. monoclonal amphetamine assay as a result of antipsychotic drug therapy [Letter]. Clin Chem 1993; 39: 549
12. Moore FML, Jarvie DR, Simpson D. Comparison of polyclonal and monoclonal assays for routine screening of urines for amphetamines. Ann Clin Biochem 1996; 33: 78-81
13. Kunsman GW, Manno JE, Cockerham KR, Manno BR. Application of Syva EMIT and Abbott TDx amphetamine immunoassays to the detection of 3,4-methylenedioxymethamphetamine (MDMA) and 3,4-methylenedioxyethamphetamine (MDEA) in urine. J Anal Toxicol 1990; 14: 149-53
14. Brown ERS, Jarvie DR, Simpson D. Use of drugs at "Raves". Scott Med J 1995; 40: 168-71
15. Hausmann E, Kohl B, Von Boehmer H, Wellhoner HH. False-positive EMIT indication of opiates and methadone in a doxylamine intoxication. J Clin Chem Clin Biochem 1983; 21: 599-600
16. Hobbs R. Near patient testing in primary care. BMJ 1996; 312: 263-4
17. DHSS Hazard Notice. Blood Glucose Measurements: Reliability of Results Produced in Extra Laboratory Areas, HN (Hazard) [87]31. London: Department of Health and Social Security, 1987
18. DoH Hazard Notice. Blood Gas Measurements: The Need for Reliability of Results Produced in Extra Laboratory Areas, HC (Hazard) [89]31. London: Department of Health, 1989
19. DoH Joint Working Group on Quality Assurance. Guidelines on the Control of Near-patient Tests (NPT) and Procedures Performed. London: Department of Health, 1992
20. DHSS. Management of Equipment, Health Equipment Information No. 98. London: Department of Health and Social Security, 1982
21. DHSS. Procurement Product Liability - Implications for the NHS of the Consumer Protection Act 1987. Health Notice HN(88). London: Department of Health and Social Security, 1988
22. R d.a.u.™ monoclonal amphetamine/methamphetamine assay. Clin Chem 1990; 36: 1391-2